标题
The role of hepatokines in NAFLD
作者
关键词
-
出版物
Cell Metabolism
Volume 35, Issue 2, Pages 236-252
出版商
Elsevier BV
发表日期
2023-02-07
DOI
10.1016/j.cmet.2023.01.006
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estimating the Effect of Liver and Pancreas Volume and Fat Content on Risk of Diabetes: A Mendelian Randomization Study
- (2022) Susan Martin et al. DIABETES CARE
- Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
- (2022) João Paulo Margiotti dos Santos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure
- (2022) Sakie Katsumura et al. Cell Metabolism
- Exerkines in health, resilience and disease
- (2022) Lisa S. Chow et al. Nature Reviews Endocrinology
- Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
- (2022) Gretchen Wolff et al. Molecular Metabolism
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
- (2022) Daniel Q. Huang et al. Cell Metabolism
- Fat-distribution Patterns and Future Type-2 Diabetes
- (2022) Hajime Yamazaki et al. DIABETES
- Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals
- (2022) Alessandro Mantovani et al. GUT
- Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis
- (2022) Ruirui Yu et al. Antioxidants
- Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment
- (2022) Nabila Bourebaba et al. BIOMEDICINE & PHARMACOTHERAPY
- Multiomics study of nonalcoholic fatty liver disease
- (2022) Gardar Sveinbjornsson et al. NATURE GENETICS
- Microbiome-derived ethanol in nonalcoholic fatty liver disease
- (2022) Abraham S. Meijnikman et al. NATURE MEDICINE
- The Stress-Responsive microRNA-34a Alters Insulin Signaling and Actions in Adipocytes through Induction of the Tyrosine Phosphatase PTP1B
- (2022) Pierre-Jean Cornejo et al. Cells
- Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
- (2021) Robert Wagner et al. NATURE MEDICINE
- Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease
- (2021) Oveis Jamialahmadi et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
- (2021) Alessandro Mantovani et al. GUT
- Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome
- (2021) Jennifer Wittwer et al. Frontiers in Immunology
- The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
- (2021) Felicia Gerst et al. DIABETOLOGIA
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
- (2021) Giovanni Targher et al. Nature Reviews Gastroenterology & Hepatology
- FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance
- (2021) Oliver Stöhr et al. Cell Reports
- Sex Hormone Binding Globulin (SHBG) Mitigates ER Stress in Hepatocytes In Vitro and Ex Vivo
- (2021) Katarzyna Kornicka-Garbowska et al. Cells
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Serum Tsukushi levels are elevated in newly diagnosed type 2 diabetic patients
- (2021) Yan-Yan Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia
- (2021) Daniel J Rader et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis
- (2021) Yani Ke et al. Lipids in Health and Disease
- Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue
- (2021) Anastasia Georgiadi et al. Nature Communications
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank
- (2021) Sanaa Tejani et al. MAYO CLINIC PROCEEDINGS
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated circulating follistatin associates with an increased risk of type 2 diabetes
- (2021) Chuanyan Wu et al. Nature Communications
- Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study
- (2021) Nooshin Ghodsian et al. Nutrients
- Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
- (2021) Tae Hyun Kim et al. Biomedicines
- Newly discovered endocrine functions of the liver
- (2021) Jane Rhyu et al. World Journal of Hepatology
- Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade
- (2020) Thomas Eigentler et al. ANNALS OF INTERNAL MEDICINE
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes
- (2020) Jonathan R. Davey et al. FASEB JOURNAL
- Liver governs adipose remodelling via extracellular vesicles in response to lipid overload
- (2020) Yue Zhao et al. Nature Communications
- Muscle-organ crosstalk: the emerging roles of myokines
- (2020) Mai Charlotte Krogh Severinsen et al. ENDOCRINE REVIEWS
- Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping
- (2020) Zhipeng Liu et al. JOURNAL OF HEPATOLOGY
- Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity
- (2020) Ji A Seo et al. Nature Communications
- Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression
- (2020) Xiongfeng Pan et al. International Journal of Environmental Research and Public Health
- Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat diet–induced obesity
- (2020) Ruhang Tang et al. Science Advances
- A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
- (2020) Tae Gyu Oh et al. Cell Metabolism
- FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes
- (2020) Gema Frühbeck et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Causes, consequences, and treatment of metabolically unhealthy fat distribution
- (2020) Norbert Stefan Lancet Diabetes & Endocrinology
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
- (2020) Daniel Gaudet et al. EUROPEAN HEART JOURNAL
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway
- (2020) Yi Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control
- (2020) Magdalene K. Montgomery et al. Science Translational Medicine
- Clusterin overexpression protects against western diet-induced obesity and NAFLD
- (2020) Jin-Sung Park et al. Scientific Reports
- Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
- (2020) Kasper W. ter Horst et al. DIABETES CARE
- Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P
- (2020) Gian Paolo Caviglia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatokines and metabolism: Deciphering communication from the liver
- (2020) Sharon O. Jensen-Cody et al. Molecular Metabolism
- Gut microbial metabolites in obesity, NAFLD and T2DM
- (2019) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- Adipogenesis and metabolic health
- (2019) Alexandra L. Ghaben et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Specificity, versatility, and control of TGF-β family signaling
- (2019) Rik Derynck et al. Science Signaling
- A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
- (2019) Steven A. Kliewer et al. Cell Metabolism
- The liver as an endocrine organ - linking NAFLD and insulin resistance
- (2019) Matthew J Watt et al. ENDOCRINE REVIEWS
- Genome-wide association study of breakfast skipping links clock regulation with food timing
- (2019) Hassan S Dashti et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis
- (2019) Meng Xu et al. CELL
- Exosomal microRNA-122 mediates obesity-related cardiomyopathy through suppressing mitochondrial ADP-ribosylation factor-like 2
- (2019) Yongshun Wang et al. CLINICAL SCIENCE
- Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome
- (2019) C. Ronald Kahn et al. JOURNAL OF CLINICAL INVESTIGATION
- What lipodystrophies teach us about the metabolic syndrome
- (2019) Jake P. Mann et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
- (2019) Martijn C. G. J. Brouwers et al. DIABETOLOGIA
- Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides
- (2019) Varman T. Samuel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- The integrative biology of type 2 diabetes
- (2019) Michael Roden et al. NATURE
- The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans
- (2018) Andreas Peter et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
- (2018) Christina C. Lindenmeyer et al. Clinics in Liver Disease
- Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A
- (2018) Jiejie Zhao et al. DIABETES
- Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis
- (2018) Janine Kröger et al. DIABETES
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- LECT2 promotes inflammation and insulin resistance in adipocytes via P38 pathways
- (2018) Tae Woo Jung et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle
- (2018) Tae Woo Jung et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
- (2018) Jonathan Pearson-Stuttard et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases
- (2018) Rajan Singh et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Publisher Correction: Inactivating hepatic follistatin alleviates hyperglycemia
- (2018) Rongya Tao et al. NATURE MEDICINE
- Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension
- (2018) Yingjie Ji et al. DIABETES
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
- (2017) Harald Staiger et al. ENDOCRINE REVIEWS
- Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity
- (2017) María del Mar Grasa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues
- (2017) Chofit Chai et al. GASTROENTEROLOGY
- The Hepatic Protection Effects of Hepassocin in Hyperglycemic Crisis
- (2017) Horng-Yih Ou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Emmanuela Gakidou et al. LANCET
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
- (2017) Ruth C. R. Meex et al. Nature Reviews Endocrinology
- Increasing Lipolysis and Reducing Atherosclerosis
- (2017) Alan R. Tall NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia
- (2017) Kumpei Tanisawa et al. PLoS One
- Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models
- (2017) Yuichiro Mita et al. Nature Communications
- Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
- (2017) Hye Jin Yoo et al. PLoS One
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes
- (2016) Hung-Tsung Wu et al. DIABETOLOGIA
- Lipodystrophy Syndromes
- (2016) Iram Hussain et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Circulating Follistatin Is Liver-Derived and Regulated by the Glucagon-to-Insulin Ratio
- (2016) Jakob S. Hansen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- Adipose tissue regulates insulin sensitivity: role of adipogenesis,de novolipogenesis and novel lipids
- (2016) U. Smith et al. JOURNAL OF INTERNAL MEDICINE
- Circulating follistatin in relation to energy metabolism
- (2016) Jakob Schiøler Hansen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance
- (2016) Luca A Lotta et al. NATURE GENETICS
- Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
- (2016) Bilgen Ekim Üstünel et al. Nature Communications
- Phenotypes of prediabetes and stratification of cardiometabolic risk
- (2016) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies
- (2015) Lars E. Laugsand et al. ATHEROSCLEROSIS
- Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism
- (2015) Ruth C. Meex et al. Cell Metabolism
- Hepatokines: unlocking the multi-organ network in metabolic diseases
- (2015) Alison Iroz et al. DIABETOLOGIA
- Novel insights in SHBG regulation and clinical implications
- (2015) Rafael Simó et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance
- (2014) Fei Lan et al. DIABETES
- Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes
- (2014) Fredrik Karpe et al. Nature Reviews Endocrinology
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies
- (2014) Norbert Stefan et al. PLoS One
- Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
- (2014) Akinobu Ochi et al. PLoS One
- Mechanisms and Metabolic Implications of Regional Differences among Fat Depots
- (2013) Tamara Tchkonia et al. Cell Metabolism
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Genetically Elevated Fetuin-A Levels, Fasting Glucose Levels, and Risk of Type 2 Diabetes: The Cardiovascular Health Study
- (2013) M. K. Jensen et al. DIABETES CARE
- Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics
- (2013) Jacklyn N. Hellwege et al. GENE
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
- (2013) Andreas L. Birkenfeld et al. HEPATOLOGY
- Measures of Adiposity and Fat Distribution and Risk of Diabetes
- (2013) Norbert Stefan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Measures of Adiposity and Fat Distribution and Risk of Diabetes—Reply
- (2013) Ian J. Neeland et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The role of Hepassocin in the development of non-alcoholic fatty liver disease
- (2013) Hung-Tsung Wu et al. JOURNAL OF HEPATOLOGY
- AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes
- (2013) Tae Woo Jung et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans
- (2013) Norbert Stefan et al. NATURE MEDICINE
- The role of hepatokines in metabolism
- (2013) Norbert Stefan et al. Nature Reviews Endocrinology
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease
- (2013) Hae Yoon Choi et al. Diabetes & Metabolism Journal
- Association of Fetuin-A With Incident Diabetes Mellitus in Community-Living Older Adults
- (2012) Joachim H. Ix et al. CIRCULATION
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- IL1β Down-regulation of Sex Hormone-Binding Globulin Production by Decreasing HNF-4α Via MEK-1/2 and JNK MAPK Pathways
- (2012) Rafael Simó et al. MOLECULAR ENDOCRINOLOGY
- Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
- (2012) Zheng Sun et al. NATURE MEDICINE
- Fetuin-A: the missing link in lipid-induced inflammation
- (2012) Jan Heinrichsdorff et al. NATURE MEDICINE
- Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
- (2012) Durba Pal et al. NATURE MEDICINE
- Potential Role of Tumor Necrosis Factor- in Downregulating Sex Hormone-Binding Globulin
- (2011) R. Simo et al. DIABETES
- The Metabolically Benign and Malignant Fatty Liver
- (2011) N. Stefan et al. DIABETES
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- (2011) Romina Lomonaco et al. HEPATOLOGY
- High Glucose Induces Transactivation of the .ALPHA.2-HS Glycoprotein Gene Through the ERK1/2 Signaling Pathway
- (2011) Hiroshi Takata et al. Journal of Atherosclerosis and Thrombosis
- Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis
- (2011) S. J. Yang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sex hormone-binding globulin and type 2 diabetes mellitus
- (2011) Trang N. Le et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance
- (2010) Suman Dasgupta et al. BIOCHEMICAL JOURNAL
- A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance
- (2010) Hirofumi Misu et al. Cell Metabolism
- Relationships of Circulating Sex Hormone-Binding Globulin With Metabolic Traits in Humans
- (2010) A. Peter et al. DIABETES
- Exercise Induces a Marked Increase in Plasma Follistatin: Evidence That Follistatin Is a Contraction-Induced Hepatokine
- (2010) Jakob Hansen et al. ENDOCRINOLOGY
- Emerging roles for the TGFβ family in pancreatic β-cell homeostasis
- (2010) Melissa L. Brown et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study
- (2009) Eva Fisher et al. Circulation-Cardiovascular Genetics
- Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance
- (2009) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure
- (2009) C. Y. Li et al. GUT
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes
- (2009) John R.B. Perry et al. HUMAN MOLECULAR GENETICS
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men
- (2009) Eric L. Ding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and Characterization of Metabolically Benign Obesity in Humans
- (2008) Norbert Stefan ARCHIVES OF INTERNAL MEDICINE
- Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
- (2008) Cornelia Weikert et al. CIRCULATION
- Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
- (2008) N. Stefan et al. DIABETES
- Causes and Metabolic Consequences of Fatty Liver
- (2008) Norbert Stefan et al. ENDOCRINE REVIEWS
- Fetuin-A and Incident Diabetes Mellitus in Older Persons
- (2008) Joachim H. Ix JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
- (2008) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus
- (2008) Katsuhito Mori et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started